Understanding the Sherman Act, Treble Damages, and ACPERA

The Sherman Act remains the foundation of federal antitrust law in the United States. Enacted in 1890, it was the first major federal antitrust statute and was intended to preserve free and unfettered competition as the governing rule of trade. The basic premise behind the statute is that open competition promotes better allocation of resources, lower prices, higher quality, and broader economic progress.

The Sherman Act’s Core Purpose

At its most basic level, the Sherman Act targets conduct that interferes with competitive markets. The statute addresses two central categories of anticompetitive behavior: restraints on trade and monopolization. Section 1 focuses on agreements that restrain trade, while Section 2 addresses monopolization, attempted monopolization, and conspiracies to monopolize.

Section 1 and Section 2

Section 1 prohibits contracts, combinations, and conspiracies in restraint of trade or commerce among the states or with foreign nations. Section 2, by contrast, addresses conduct aimed at monopolizing a market or attempting to do so. Together, these provisions form the backbone of federal antitrust enforcement.

Treble Damages Under § 4 of the Clayton Act

Where there has been a violation of the Sherman Act, an injured party may pursue the treble-damages remedy available under § 4 of the Clayton Act. That remedy can significantly increase potential exposure in antitrust litigation. But treble damages are not automatic in every case, and they will be denied where the claimed damages are speculative.

Fraudulently Procured Patents and § 2 of the Sherman Act

In a patent case of first impression, the Supreme Court explained that liability may arise where there is intentional fraud consisting of a knowing and willful misrepresentation of material facts. The Court made clear that this requires more than a mere technical fraud or an honest mistake in judgment.

According to the Court, enforcement of a patent procured by fraud on the Patent Office may violate § 2 of the Sherman Act, provided the remaining elements of a § 2 claim are also satisfied. In that circumstance, the treble-damages remedy under § 4 of the Clayton Act may be available to an injured party.

More specifically, a violation of § 2 of the Sherman Act may be maintained under § 4 of the Clayton Act if two conditions are met: first, the patent must have been procured through knowing and willful fraud on the Patent Office, or enforced with knowledge of that fraud; and second, the plaintiff must establish the remaining elements necessary to prove monopolization under § 2. By contrast, this private antitrust remedy does not extend to monopolies carried on under a patent that was not procured through fraud.

State Antitrust Law

Federal antitrust law is only part of the picture. Nearly every state also has its own antitrust statutes, and those laws are generally patterned after the Sherman Act. The source text notes that thirty-five states and the District of Columbia have effectively repealed Illinois Brick in some form and are referred to as repealer states, while fifteen states remain non-repealer states.

What ACPERA Does

The Antitrust Criminal Penalty Enhancement and Reform Act of 2004 (“ACPERA”) was enacted to increase incentives for antitrust whistleblowers. It also provides an important limitation on civil damages for certain defendants that receive criminal leniency from the Antitrust Division. If such a defendant “has provided satisfactory cooperation to” the civil plaintiffs, its liability may be limited to single damages instead of treble damages. Congress later amended ACPERA in 2010 and extended the statute into 2020.

In practical terms, ACPERA allows applicants who admit violating the Sherman Act to avoid some of the harsher consequences of Department of Justice enforcement, including the treble-damages component that would otherwise apply in civil litigation.

ACPERA’s Reach in Federal and State Cases

By its express terms, ACPERA applies in “any civil action alleging a violation of section 1 or 3 of the Sherman Act, or alleging a violation of any similar State law.” As a result, ACPERA limits recovery to single damages in both federal antitrust actions and state antitrust actions against qualifying ACPERA participants.

Although ACPERA does not entirely preempt the assertion of state antitrust claims, federal law will preempt state law to the extent that state law conflicts with federal law or impedes its enforcement. The source text explains that Congress effectively extended relief from treble-damages exposure under both federal and state antitrust law to ACPERA participants. Accordingly, damages against those participants are limited to single damages under either body of law.

Conflict Preemption and State Treble-Damages Statutes

Where ACPERA’s single-damages limitation conflicts with a state statute authorizing treble damages, the doctrine of conflict preemption applies and bars recovery of state antitrust treble damages from an ACPERA participant. At the same time, that conflict preemption principle does not strip state courts of subject matter jurisdiction over state-law antitrust claims brought against ACPERA participants.

Why It Matters

Taken together, the Sherman Act, § 4 of the Clayton Act, and ACPERA show how antitrust law operates not only to prohibit anticompetitive conduct, but also to shape the remedies available when violations occur. The result is a framework in which liability, damages, fraud-based patent enforcement, whistleblower incentives, and preemption principles all intersect.